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ABSTRACT
To summarize the historical events and drivers underlying public policy for the prevention 
and control of healthcare-associated infections in Brazil and in the United Kingdom. In doing 
so, the article aims to identify lessons and recommendations for future development of public 
policy. The analysis is based on a historical overview of national healthcare-associated infections 
programs taken from previously published sources. Findings highlight how the development of 
healthcare-associated infections prevention and control policies followed similar trajectories 
in Brazil and the United Kingdom. This can be conceptualized around four sequential phases: 
Formation, Consolidation, Standardization, and Monitoring and Evaluation. However, while we 
identified similar phases of development in Brazil and the United Kingdom, it can be seen that 
the former entered each stage around 20 years after the latter.
DESCRIPTORS: Cross Infection, prevention & control. Infection Control, organization & 
administration Public Health Policy. Public Health, history. 
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INTRODUCTION
Healthcare-associated infections (HAI) are a public health concern worldwide. According to 
the World Health Organization (WHO), nations should have HAI Programs (HAIP) at national 
and local (healthcare settings) levels32. A national program is intended to regulate, provide 
guidance, promote, and supervise compliance with regulations32. The HAIP at local level 
aim to prevent the occurrence of HAI in patients, healthcare workers, and visitors. Well 
established HAIP are required to deal with outbreaks.
The HAIP vary among countries, resulting in differences in outcomes of HAI rates. Therefore, 
there is scope for considerable cross-national learning. Studying the processes by which 
HAIP have been developed in different countries over time will help us to understand the 
trajectory of change and to identify areas for improvement.
The objective of this study was to identify the main drivers and events underlying the 
development of public policies on HAI prevention and control (P&C) in two countries and 
draw out policy lessons from historical experience. Brazil and the United Kingdom (UK) 
were selected as both have healthcare systems informed by the Beveridge model, involving 
government funding of healthcare services, financed by general taxation15,27.
We conducted a historical overview of national HAIP, by an open-ended review of published 
sources describing key policy developments. From this literature, we identified four sequential 
phases for the development of HAI P&C policies at national level. Formation (development 
of infection prevention techniques and practices); Consolidation (acknowledgement of 
HAI as a public health problem and development of the initial proposals of national HAIP); 
Standardization (consolidation of HAIP and establishment of nation-wide regulations); 
Monitoring and Evaluation (full establishment of HAIP at national level including mechanisms 
for measurement; recognition of HAI as a relevant patient safety issue, focus on continuous 
quality improvement and cost savings). As presented below (summarized on Figure), elements 
of each of these four phases were seen in both countries, albeit in different periods.
United Kingdom
Formation. In the early of the 20th century, the UK saw significant scientific discoveries on 
P&C, despite considerable regional variations in healthcare practices. The inauguration 
of the National Health Service (NHS) in 194831 saw the beginning of national initiatives to 
reduce HAI, and epidemics of Staphylococcus aureus during the 1950s brought these issues 
to wider public attention.
Consolidation. During the 1960s, the P&C of HAI was placed as an essential component for 
healthcare practices. This included the formal establishment of infection control as a nursing 
specialty, as well as the inauguration of working groups, conferences, and journals. These 
activities helped to raise the concern about HAI at the national and politics level.
Standardization. Changes to national policy related to healthcare organizations settled legal 
responsibility of individual providers for effective HAIP. In addition, publications of detailed 
national guidelines, and reporting mechanisms as scientific and professional communities 
increasingly gained a place in policy level decision making, such as through the National 
Institute of Clinical Excellence. Together, these developments raised HAIP compliance.
Monitoring and Evaluation. Currently, HAIP are well embedded into national healthcare 
activities and organizations; guidance on P&C and surveillance systems are under the Public 
Health England authority. Each country within the UK has its own HAIP led by national 
public health bodies based on similar principles and practices. Practice is shaped by national 
evidence-based guidelines16 and broad principles of best practice with the aim of integration 
into routine practice. A national surveillance program for HAI covers Staphylococcus aureus, 
Escherichia coli, Clostridium difficile, surgical site infections, and patients with urinary catheter, 
producing annual reports. In 2015, there was an increased policy focus on antibiotic resistance 
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and antibiotics over prescription following reports of continued overuse24. This also includes 
providing operational guidance for health teams regarding the prevention and management of 
HAI for all healthcare settings including the National Health Service and the private sector. As a 
result, a downward trend in HAI rates13 is reported, from point prevalence surveys.
Brazil
Formation. The start of HAIP in Brazil dated of the 1960s, with the formal creation of the 
first Infection Control Committee (ICC) in the state of Rio Grande do Sul1. By the end of the 
political military regime, the fact that the first civil president in 1985 supposedly died due 
to HAI fostered a visibility of the role of ICC. At the time, HAI P&C initiatives were led by 
a In line with this awareness, training materials on surgical infection were created. Examples include the films: “Aseptic operating theatre technique”2 
(1933), “Modern aseptic operating technique”17 (1933) and “The medical application of sulphonamides”29 (1948).
b As the result of the 1959 pandemic of Staphylococcus aureus infections, in April 1959 the first infection control nurse (ICN) was appointed at Torbay 
hospital, district of Exeter23. 
c The first Infection Control Committee was established in the State of Rio Grande do Sul (Hospital Ernesto Dornelles) in 19631. 
d As part of this movement, in 1966,17 infection control nurses participated in the first infection control conference at Lyngford House in Taunton, Somerset (UK)14.
e In 1970, the Infection Control Nurses Association (ICNA) is formed14. By 1979, 64% of health districts had appointed an ICN23. During the 1970s, several 
peer reviewed journal articles on infection control were published. Examples include: Bagshawe et al.5, Heddell and Mitchell12, and Barr and Hogg6.
f The death of President Tancredo Neves in 1985 allegedly by HAI raised the awareness of HAI. Advances in the field included the establishment of the first 
association of specialists in infection control in 1987, the creation of a National Training Program on Healthcare Associated Infection (HAI) from Ministry 
of Health in 1987, and the beginning of the enactment of regulations on infection control at hospitals (e.g., Portaria 196/MS of 24th June 1983 and 
Portaria 15, of 23rd August 1988).
g Examples of documents supporting this movement include: the ‘Griffiths Report’ published in 1983, which defined general managers in NHS 
organizations (NHS Trusts) with ultimate responsibility for performance and quality; and ‘The Cooke Report’ published in 1988 by the Department of 
Health and Social Security, working with the Public Health Laboratory Service, which included guidance on hospital infection control.
h Regulations on infection control included: (i) the Ordinance 930/92 (1992) from Ministry of Health, which included normatives for infection control at 
hospitals, (ii) the Law 9,431 of 6th January 1997, which introduced the compulsory requirement of an Infection Control Program and Infection Control 
Committee at hospitals, and (iii) the Law 2,616 of 12th May 1998, which established minimum infection control measures for Hospital’s Infection Control 
Units. In 1995, the first national large prevalence study was conducted, including 99 hospitals. In 1999, the National Sanitary Agency (ANVISA) was 
established with regulatory powers on HCAI. 
i Examples of standards included: (i) Infection Control Standards Working Party (1993), Standards in infection control in hospitals. Public Health 
Laboratory Service: London; and (ii) Department of Health (1995), Hospital Infection Control: Guidance on the Control of Infection in Hospitals. London: 
Department of Health. In 1999, the National Institute for Clinical Excellence (NICE) was stablished. NICE issues clinical guidelines, patient pathways, cost 
effectiveness, and research evidence synthesis, including on HAI.
j Examples of this trend included: (i) the creation of UCISA (Hospital Infection Control Unit), designated to deal with the National HAI Prevention 
& Control Program (2000); (ii) the first governmental surveillance system for HCAI in the State São Paulo (2004); (iii) the beginning of the National 
Governmental Surveillance System (ANVISA) (2011); and (iv) the creation of the National Infection Prevention and Control Committee with expert to 
support the National HCAI Prevention and Control Program (2012). 
k In 2001, the Health Protection Agency (HPA) was established to monitor patient safety incidents, oversaw safety aspects of hospital design, cleanliness and food. 
In 2001, the National Patient Safety Agency (NPSA) was created as a Special Health Authority to monitor patient safety incidents including HCAI incidents. In 
2004, the Healthcare Commission (HC) began assessing organisations on their policies and procedures for prevention and control of HCAI. In 2009, the Care 
Quality Commission (CQC) took over from HC and continued a programme of inspections with additional powers relating to cleanliness and infections.
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individual professional associations. In 1987, the São Paulo Association of Infection Control 
and Epidemiology (APECIH – Associação Paulista de Epidemiologia e Controle de Infecção 
Relacionada à Assistência à Saúde) was founded, offering a central point of focus for the P&C 
of HAI, disseminating scientific knowledge and bringing together professional activities in 
the area. In the same year, the National Association of Professionals (ABIH – Associação 
Brasileira dos Profissionais em Controle de Infecção e Epidemiologia Hospitalar) was created 
and subsequently, the Ministry of Health began a national training programa.
Consolidation. In the decade of 1980s, the creation of the Unified Health System (SUS) established 
health as a right in the country9. Subsequently, the 1990s saw increasing consolidation of HAI 
P&C at the policy level. National regulations were reviewed, culminating in a law making it 
compulsory for all hospitals to establish an ICC. The first national HAI prevalence study was 
carried out in the 1990s, although a follow-up study was not conducted for nearly 20 years21,26.
Standardization. Standardization in Brazil can be seen to gather pace following outbreaks of 
HAI in the late 1990s. This includes the 1996 outbreak of intoxication by cyanobacteria at a 
hemodialysis unit in Caruaru, Northeastern Brazil, due to the use of improperly treated water, 
leading to 126 HAI cases and 60 deaths25. Further outbreaks of fast growing Mycobacteriab and 
multidrug resistant microorganisms have triggered the development of further regulations 
by the National Sanitary Agency (ANVISA)4,7,18,20,30. Standardization was strengthened by 
the 1998 Ministry of Health regulation defining the role of national, state, and municipal 
surveillance systems to monitor and evaluate P&C of HAI nationwide (Figure). 
Currently, the coordination of the national HAIP is carried out by ANVISA, which sets the 
basic elements for P&C of HAI, including written guidelines and a surveillance system. This 
system is targeted at catheter-related bloodstream infections at the intensive care units and 
high risk nurseries and surgical site infectionc. A system for outbreak notificationd is in place 
and the National HAIP is publicly availablee.
Since 2000, ANVISA established working groups involving experts to develop guidelines on 
P&C of HAI and also created the National Infection P&C Committee to support the national 
HAIP. Recently, Brazil initiated a patient safety program at the national level19.
Data from the national surveillance system shows a huge variation in HAI rates among 
the statesf. There is also heterogeneity at the local level, with some hospitals having well 
established HAIP, while others have almost no initiatives in this area19,21.
FINAL CONSIDERATIONS
Across the two countries, we found similarities in the phases of HAI public policy, though, 
when compared to the UK, the start of each phase in Brazil took place around 20 years later. 
Of note, our analysis sought to identify trends in the HAIP at national level, rather than 
considering local practices, which are likely to vary greatly.
This article focuses on the development of HAI public policies in Brazil and in the UK. 
However, other factors may have influenced the attention surrounding HAI. From the start, 
in the past decades, there were significant differences in the economic, cultural, and political 
landscape of the two countries. Second, although both healthcare systems are informed 
by the Beveridge model, the way each system is organized may affect the perspectives of 
HAI prevention10. The NHS began in the UK in 1948, while in Brazil, the SUS was not fully 
developed until the 1990s. Whereas in the UK free and comprehensive healthcare provision 
dates from the late 1940s, in Brazil, health as a citizen’s right and a duty of the state was only 
recognized with the promulgation of a new constitution in 1988. The principles of universality, 
comprehensiveness, and social participation adopted by the SUS did not exist before22. This 
perception of citizen’s rights is probably associated with the raising of awareness of the 
importance of P&C of HAI. Hence, this can be a relevant driven force to promote P&C policies. 
Worldwide, healthcare systems are evolving and encompassing more complex and diverse 
a National Training Program on 
HCAI – The Brazilian Ministry of 
Health (MoH) used the strategy 
of “training the trainers”. Initially, 
a centralized training program 
occurred in Brasilia, Federal 
District. After that, the training 
program was carried out at 
national level using voluntary 
training centers and their staff. All 
didactic material was provided by 
the MoH.
b Agência Nacional de Vigilância 
Sanitária. Relatório descritivo 
de investigação de casos de 
infecções por micobactérias não 
tuberculosas de crescimento 
rápido (MCR) no Brasil no 
período de 1998 a 2009. Brasília 
(DF): ANVISA; 2011[cited 2011 




c Agência Nacional de Vigilância 
Sanitária. Segurança do paciente. 
Brasília (DF): ANVISA; s.d. [cited 
2015 May 30]. Available from: 
https://www20.anvisa.gov.br/
segurancadopaciente/
d Ministério da Saúde (BR), 
DATASUS. Formsus: versão 3.0: 
Notificação de agregado de 
casos e surto em serviços de 
saúde. Brasília (DF): DATASUS; 
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paciente: PNPCIRAS 2016-2020 
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Sanitária. Segurança do paciente. 
Brasília (DF): ANVISA; s.d. [cited 
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environments of care (e.g. primary and secondary care, community care, etc.)10,15. Therefore, 
strategies to prevent HAI should also evolve in order to be able to deal with this diversity.
Findings also suggest that additional international trends shaped HAI public policy 
developments. Namely, the cultural and political affinities between the UK and the USA 
facilitated the sharing of evidence and practice between the two countries. For example, the 
US SENIC study (1980)11 demonstrated that effective programs could reduce at least 30% of 
HAI and gained widespread policy attention in the UK. However, we saw the influence from 
international studies being exerted much later in Brazil.
Evidence suggests that Brazil only developed scientific critical mass on the issue of HAI in the 
1990s. Since then, the exchange between Brazilian and international researchers in this field 
promoted knowledge transfer and discussions on the feasibility of translating to the Brazilian 
context techniques and systems applied elsewhere28. Alongside the development of HAI 
research in Brazil, scientists have been asked by ANVISA to contribute in the Standardization 
process. In Brazil, we now see a better synchronicity between the scientific understanding and 
the HAI public policy that has allowed the country to arrive at the stages of Consolidation 
and Standardization. Further, stemming from our historical comparative overview, we 
would suggest that Brazil is likely to enter into a phase of Monitoring and Evaluation, which 
is already established in the UK. The influence of international bodies such as the WHO 
may have played a role in advancing the HAI subject, particularly in developing countries.
Another important driver of the development of HAIP in both countries was the attention 
brought by the occurrence of relevant outbreaks. In the two countries outbreaks and 
subsequent media campaigns led to periods of increased public and political sensitivity to 
the issue. The raising of awareness of legal and civil rights for the provision of quality and 
safe healthcare appeared to be a key pressure point for the processes of Standardization.
Patient safety has been accepted as a worldwide problem to be tackled and HAI rates are 
recognized as a key indicator of quality of care. Safer care can be seen as a shared goal in high 
and middle-income countries, and our study recognizes points of common development 
in HAIP in the UK and Brazil. Nevertheless, there remain significant differences between 
the two countries. In comparative terms, Brazil has to overcome multiple political and 
economic challenges in order to advance universal healthcare provision8. Indeed, for many 
middle-income countries, basic access to healthcare continues to be a problem for some 
portions of the population, and wherever this is the case, the prevention of HAI may be seen 
as a secondary concern3. A good balance between healthcare access, economic sustainability, 
and patient safety is the challenge for healthcare systems worldwide.
The analysis of the UK experience highlights several potentially useful lessons for health 
systems that have not yet reached the Monitoring and Evaluation phase. Amongst them, the 
need to consider HAI as a public health problem, consistent dissemination of evidence based 
guidelines, integration of scientific updates in the clinical practice, setting up of guidance 
addressed to different types of healthcare settings, and monitoring of epidemiologically 
relevant pathogens. Finally, citizen’s engagement in the HAI policy making is highly desirable.
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